Salutaris Medical Devices, Inc. announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018. Dr. Gregg Kokame, Principal Investigator (PI) at the clinical site in Honolulu successfully performed the first procedure using the SMD-DA device on May […]
Regenesis Biomedical, a Scottsdale-based medical device company, has initiated a multi-center, randomized clinical trial assessing the Provant® Therapy System for relieving symptoms of painful diabetic distal symmetric peripheral neuropathy (DSPN). Painful neuropathy affects over 3 million people in the United States, resulting in nerve damage in the extremities such as tingling, numbness, pain and sensitivity […]
HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A. (“Firalis”), a provider of bioanalytical services and biomarker-based products and services, today announced a non‑exclusive license and supply agreement (“Agreement”) that will enable Firalis to commercialize a next‑generation sequencing (NGS)‑based theranostic product and services to […]
For some, the words “financial aid” stirs up reminders of grueling applications and the anxiety of coping with skyrocketing college tuition. Phoenix-based CampusLogic aims to chip away at some of those challenges by helping institutions manage and award financial aid to more students, as well as reduce student borrowing by connecting colleges with private grant […]
CampusLogic, the leading student financial services (SFS) platform, today announced $55 million in funding led by JMI Equity, a growth equity firm focused on investing in leading software companies. Founded in 2011, CampusLogic is a market leader in SFS software with nearly 500 higher education customers that serve more than three million students. CampusLogic, which […]
HTG Molecular Diagnostics, Inc.(Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the issuance of Japan Patent Number 6290202 for “Nuclease Protection Methods for Detection of Nucleotide Variants.” The patented technology involves a nuclease-protection method using wild‑type and variant probes competing for binding to a target nucleic acid molecule, such […]
Beyond space exploration, these high-potential startups are leveraging data from small satellites to increase military surveillance, predict the weather, and more. Just ten years ago, it cost millions of dollars (up to $1B) to build a satellite and launch it into outer space – limiting the market for “sats” largely to high-tech companies and government entities. But […]
Marianne Hudson, executive director of the Angel Capital Association (the trade association for angel investors in the US) wrote an article making the case for wealthy to consider becoming angel investors. Her full article (with her permission) appears below: The Case For Being An Angel Investor
Cancer Prevention Pharmaceuticals, Inc. (CPP), a private clinical stage biotech company developing novel therapeutics to prevent cancer and other diseases, announced today the appointment of Willene Brondum as its new Associate Vice President of Regulatory Affairs and Quality Assurance. Ms. Brondum will lead all of CPP’s regulatory and quality assurance operations for its advancing pipeline […]
Don’t tell Ketan Patel that something can’t be done. He’s likely to take it as a challenge, invent new technology and start a company so cutting edge it wins the Arizona Innovation Challenge. That’s essentially how Naya Energy came to be. A colleague developed a smart meter to track how a company uses electricity. Patel, […]